Zoetis Stock News

I present my top 15 high-growth dividend stocks to consider during the month of April. The watchlist posted a gain of 2.02% in March, finishing ahead of VIG but trailing SPY.

In 2022, healthcare stocks surpassed the S&P 500. But in 2023, they are not doing so well.

Finding S&P 500 stocks that analysts agree on is rare. So when you see nearly unanimous agreement on some, that's quite a statement.

Zoetis (ZTS) closed at $164.47 in the latest trading session, marking a -1.11% move from the prior day.

Nike, Salesforce, Zoetis, Archer-Daniels-Midland and Trane Technologies are part of the Zacks top Analyst Blog.

Today's Research Daily features new research reports on 16 major stocks, including NIKE, Inc. (NKE), Salesforce, Inc. (CRM) and Zoetis Inc. (ZTS).

Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Markets are in turmoil. Hence, in this article, we start with a discussion of the risks facing investors and why I believe in attractive buying opportunities this year. While I understand that investo

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the companies with upcoming ex-dividend dates.

I present my top 15 high-growth dividend stocks to consider during the month of March. The watchlist posted loss of 2.94% in February, finishing behind VIG and SPY on the month.

COLL vs. ZTS: Which Stock Is the Better Value Option?

COLL vs. ZTS: Which Stock Is the Better Value Option?

On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named Zoetis Inc (NYSE: ZTS) as her final trade. Jason Snipe of Odyssey Capital Advisors said Arista Networ

Weekly summary of dividend activity for Dividend Champions, Contenders, Challengers. Read more to see the companies with upcoming ex-dividend dates.

The "Halftime Report" traders give their top picks to watch for the second half.